Skip to main content
Clinical Trials/jRCTs042180129
jRCTs042180129CompletedNot Applicable

Feasibility, safety, effectiveness, and economical efficiency of robotic gastrectomy for resectable gastric cancer: a multi-institutional historically controlled prospective cohort study

Not provided0 sites330 target enrollmentStarted: October 17, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
330
Primary Endpoint
-

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomized Controlled Trial
Intervention Model
Single Assignment
Primary Purpose
Treatment Purpose
Masking
Open(masking Not Used)

Eligibility Criteria

Ages
18age old over to No limit (—)
Sex
All

Inclusion Criteria

  • •Operable patients under general anesthesia
  • •Histologically diagnosed gastric adenocarcionoma
  • •cStage I or II disease curably treated with total, distal, or proximal gastrectomy with D1+ or D2 lymph node dissection
  • •Not indicated for endoscopic resection
  • •Age over 18
  • •Informed consent is obtained

Exclusion Criteria

  • •Patients with mental disorders
  • •Preoperative use of chemotherapy

Outcomes

Primary Outcomes

-

Postoperative complications greater than Grade III according to Clavien-Dindo classification

Secondary Outcomes

  • Postoperative Complications grater than Grade II
  • Health outcomes measured by EuroQol 5 Dimension (EQ-5D)
  • Total Medical Cost
  • Overall survival
  • Disease free survival
  • Robotic gastrectomy success rate
  • Conversion to laparotomy
  • Intraoperative adverse effects
  • Surgical outcomes
  • Postoperative courses
  • Surgery-Related Mortality

Investigators

Sponsor
Not provided

Similar Trials